Spironolactone Therapy in Chronic Stable Right HF Trial

Clinical trial NCT03344159 · COMPLETED

Trial details

NCT number: NCT03344159
Sponsor: Ottawa Heart Institute Research Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Right-Sided Heart Failure Pulmonary Arterial Hypertension Pulmonary Hypertension, Primary, 2 Pulmonary Hypertension, Primary, 3 Pulmonary Hypertension, Primary, 4 Cardiomyopathy Right Ventricular

Start date: 2018-04-01
Primary completion: 2022-08-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.